New Psychedelic Drug Therapies Are More Effective Than Traditional Therapies

Venture capital investors have poured well over $100 million into companies developing treatments with psychedelics. New York-based Transcend Therapeutics develops psychoactive medicines for neuropsychiatric diseases, including post-traumatic stress disorder. It's likely that the Food and Drug Administration will approve the use of these psychedelics within the coming years.